journal article Open Access Mar 17, 2022

Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia

View at Publisher Save 10.1038/s41598-022-08641-y
Abstract
AbstractVitamin D insufficiency/deficiency has been linked to an increased risk of preeclampsia. Impaired placental amino acid transport is suggested to contribute to abnormal fetal intrauterine growth in pregnancies complicated by preeclampsia. However, if vitamin D-regulated amino acid transporter is involved in the pathophysiologic mechanism of preeclampsia has not been clarified yet. The aberrant expression of key isoform of L-type amino acid transporter LAT1 was determined by western blot and immunohistochemistry in the placenta from normotensive and preeclamptic pregnancies. The role for vitamin D on placental LAT1 expression was investigated through the exposure of HTR-8/SVneo human trophoblast cells to the biologically active 1,25(OH)2D3 and the oxidative stress-inducer cobalt chloride (CoCl2). Our results showed that placental LAT1 expression was reduced in women with preeclampsia compared to normotensive pregnancies, which was associated with decreased expression of vitamin D receptor (VDR). 1,25(OH)2D3 significantly upregulated LAT1 expression in placental trophoblasts, and also prevented the decrease of mTOR activity under CoCl2-induced oxidative stress. siRNA targeting VDR significantly attenuated 1,25(OH)2D3-stimulated LAT1 expression and mTOR signaling activity. Moreover, treatment of rapamycin specifically inhibited the activity of mTOR signaling and resulted in decrease of LAT1 expression. In conclusion, LAT1 expression was downregulated in the placenta from women with preeclampsia. 1,25(OH)2D3/VDR could stimulate LAT1 expression, which was likely mediated by mTOR signaling in placental trophoblasts. Regulation on placental amino acid transport may be one of the mechanisms by which vitamin D affects fetal growth in preeclampsia.
Topics

No keywords indexed for this article. Browse by subject →

References
37
[1]
Phipps, E. et al. Preeclampsia: Updates in pathogenesis, definitions, and guidelines. Clin. J. Am. Soc. Nephrol. 11, 1102–1113 (2016). 10.2215/cjn.12081115
[2]
Wu, P. et al. Preeclampsia and future cardiovascular health: A systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes. https://doi.org/10.1161/CIRCOUTCOMES.116.003497 (2017). 10.1161/circoutcomes.116.003497
[3]
Redman, C. W. & Sargent, I. L. Latest advances in understanding preeclampsia. Science 308, 1592–1594 (2005). 10.1126/science.1111726
[4]
Brett, K. E. et al. Maternal-fetal nutrient transport in pregnancy pathologies: The role of the placenta. Int. J. Mol. Sci. 15, 16153–16185 (2014). 10.3390/ijms150916153
[5]
Desforges, M. & Sibley, C. P. Placental nutrient supply and fetal growth. Int. J. Dev. Biol. 54, 377–390 (2010). 10.1387/ijdb.082765md
[6]
Zaugg, J. et al. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport. J. Cell Mol. Med. 24, 12681–12693 (2020). 10.1111/jcmm.15840
[7]
Castillo-Castrejon, M. et al. Effect of type 2 diabetes mellitus on placental expression and activity of nutrient transporters and their association with birth weight and neonatal adiposity. Mol. Cell Endocrinol. 532, 111319 (2021). 10.1016/j.mce.2021.111319
[8]
Chen, Z. et al. PPARgamma stimulates expression of L-type amino acid and taurine transporters in human placentas: The evidence of PPARgamma regulating fetal growth. Sci. Rep. 5, 12650 (2015). 10.1038/srep12650
[9]
Wang, X. et al. Positive regulation of placentation by L-amino acid transporter-1 (lat1) in pregnant mice. Int. J. Clin. Exp. Pathol. 10, 9551–9558 (2017).
[10]
Chrostowski, M. K. et al. Role of the L-amino acid transporter-1 (LAT-1) in mouse trophoblast cell invasion. Placenta 31, 528–534 (2010). 10.1016/j.placenta.2009.12.010
[11]
Roos, S. et al. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am. J. Physiol. Cell Physiol. 296, C142–C150 (2009). 10.1152/ajpcell.00330.2008
[12]
Rosario, F. J. et al. Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells. J. Physiol. 591, 609–625 (2013). 10.1113/jphysiol.2012.238014
[13]
Xu, J. et al. Downregulation of placental amino acid transporter expression and mTORC1 signaling activity contributes to fetal growth retardation in diabetic rats. Int. J. Mol. Sci. 21, 1849 (2020). 10.3390/ijms21051849
[14]
Kiely, M. E. et al. Vitamin D in pregnancy: Where we are and where we should go. J. Steroid Biochem. Mol. Biol. 201, 105669 (2020). 10.1016/j.jsbmb.2020.105669
[15]
Khaing, W. et al. Calcium and vitamin D supplementation for prevention of preeclampsia: A systematic review and network meta-analysis. Nutrients 9, 1141 (2017). 10.3390/nu9101141
[16]
Cao, Y. et al. Vitamin D stimulates miR-26b-5p to inhibit placental COX-2 expression in preeclampsia. Sci. Rep. 11, 11168 (2021). 10.1038/s41598-021-90605-9
[17]
Xu, J. et al. Vitamin D reduces oxidative stress-induced procaspase-3/ROCK1 activation and MP release by placental trophoblasts. J. Clin. Endocrinol. Metab. 102, 2100–2110 (2017). 10.1210/jc.2016-3753
[18]
Westwood, M. et al. Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration. Placenta 60, 1–8 (2017). 10.1016/j.placenta.2017.09.009
[19]
Pi, Y. et al. Vitamin D alleviates hypoxia/reoxygenation-induced injury of human trophoblast HTR-8 cells by activating autophagy. Placenta 111, 10–18 (2021). 10.1016/j.placenta.2021.05.008
[20]
Li, G. et al. 1,25(OH)2D3 protects trophoblasts against insulin resistance and inflammation via suppressing mTOR signaling. Reprod. Sci. 26, 223–232 (2019). 10.1177/1933719118766253
[21]
Cleal, J. K. et al. Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: Results from the Southampton Women’s Survey. Br. J. Nutr. 113, 1903–1910 (2015). 10.1017/s0007114515001178
[22]
Xu, J. et al. Reduced CD200 expression is associated with altered Th1/Th2 cytokine production in placental trophoblasts from preeclampsia. Am. J. Reprod. Immunol. 79, e12763 (2018). 10.1111/aji.12763
[23]
Mirzakhani, H. et al. Early pregnancy vitamin D status and risk of preeclampsia. J. Clin. Investig. 126, 4702–4715 (2016). 10.1172/jci89031
[24]
Agarwal, S. et al. Vitamin D and its impact on maternal-fetal outcomes in pregnancy: A critical review. Crit. Rev. Food Sci. Nutr. 58, 755–769 (2018). 10.1080/10408398.2016.1220915
[25]
Bell, A. W. & Ehrhardt, R. A. Regulation of placental nutrient transport and implications for fetal growth. Nutr. Res. Rev. 15, 211–230 (2002). 10.1079/nrr200239
[26]
Aiko, Y. et al. Differential levels of amino acid transporters system L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR. BMC Pregn. Childbirth 14, 181 (2014). 10.1186/1471-2393-14-181
[27]
Malina, A. et al. Placental system A transporter mRNA is not different in preeclampsia, normal pregnancy, or pregnancies with small-for-gestational-age infants. Hypertens. Pregn. 24, 65–74 (2005). 10.1081/prg-45780
[28]
Shibata, E. et al. Placental system A amino acid transport is reduced in pregnancies with small for gestational age (SGA) infants but not in preeclampsia with SGA infants. Placenta 29, 879–882 (2008). 10.1016/j.placenta.2008.07.001
[29]
Huang, X. et al. Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia. BMC Genomics 19, 173 (2018). 10.1186/s12864-018-4518-z
[30]
Fotiadis, D. et al. The SLC3 and SLC7 families of amino acid transporters. Mol. Aspects Med. 34, 139–158 (2013). 10.1016/j.mam.2012.10.007
[31]
Mikolajek-Bedner, W. et al. Pregnancy delivery and puerperium in a patient with lysinuric protein intolerance—A case report. Ginekol. Pol. 84, 654–656 (2013).
[32]
von Versen-Hoeynck, F. M. & Powers, R. W. Maternal-fetal metabolism in normal pregnancy and preeclampsia. Front. Biosci. 12, 2457–2470 (2007). 10.2741/2247
[33]
Chen, Y. Y. et al. 1,25-Dihydroxy vitamin D3 stimulates system A amino acid transport in primary human trophoblast cells. Mol. Cell Endocrinol. 442, 90–97 (2017). 10.1016/j.mce.2016.12.009
[34]
Lisse, T. S. et al. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J. 25, 937–947 (2011). 10.1096/fj.10-172577
[35]
Slominski, A. T. et al. In vivo evidence for a novel pathway of vitamin D(3) metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 26, 3901–3915 (2012). 10.1096/fj.12-208975
[36]
Slominski, A. T. et al. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci. Rep. 5, 14875 (2015). 10.1038/srep14875
[37]
Slominski, A. T. et al. Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols. Sci. Rep. 7, 11434 (2017). 10.1038/s41598-017-10202-7
Metrics
9
Citations
37
References
Details
Published
Mar 17, 2022
Vol/Issue
12(1)
License
View
Funding
National Natural Science Foundation of China Award: 82001577
China Postdoctoral Fund Award: 2018M640304
Heilongjiang Postdoctoral Foundation Award: LBH-Z18108
University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province Award: UNPYSCT-2018054
Cite This Article
Xiaotong Jia, Yang Cao, Lingyu Ye, et al. (2022). Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-08641-y